Wellbeing Digital Sciences Announces the Appointment of Natalie Dolphin as VP of Marketing and Investment Relations
Ms. Dolphin is a key strategic addition to the team, and will have an impact on the corporate strategy and growth opportunities of the company
Vancouver, British Columbia, June 21, 2022 / Globe Newswire / – WellbeingDigital Sciences Inc. (“Wellbeing” or the “Company”)(NEO: MEDI) (OTC: KONEF) (FRA: SQ2), an evidence-based mental health care company focused on the development and implementation of innovative clinical solutions, including psychedelic medicine and digital therapeutics as supported by clinical research, is very pleased to announce the appointment ofMs. Natalie Dolphin as the Vice President of Marketing and InvestmentRelations.
As VP of Marketing and Investment Relations, Ms. Dolphin brings over 15 years of experience in marketing, business development and capital markets. Natalie held a managerial role at theCanadian Securities Exchange (CSE), enabling companies to go public, in addition to helping with series A and B funding opportunities. Prior to joining Wellbeing, she served as the Director of Marking at MagicMed Industries subsequently, acquired by Nasdaq listed Enveric Biosciences Inc., where she held the same title. As part of the executive leadership team,Natalie will be responsible for overseeing the planning and execution ofWellbeing’s North American marketing and investment relations strategy.
“Natalie is an outstanding addition to our Wellbeing team, having an exceptional record of leading successful marketing programs in her previous positions and will be able to focus attention on highlighting our high-quality assets and longer-term growth initiatives in the capital markets,” said Najla Guthrie, CEO of Wellbeing. “We are thrilled to welcome Natalie to the team as we continue to expand our clinical network, in addition to our contract research capabilities and digital therapeutics partnerships, to meet the evolving needs of the market. I’m confident Natalie’s experience and marketing leadership will enable us to bring meaningful and effective solutions to not only our partners in the industry looking to further develop their assets but to also create meaningful dialogue with an expanding patient base.”
“I am honoured to join the Wellbeing team and thrilled to build on the Company’s solid foundation as a leading evidence based mental health company focused on the development and implementation of innovative clinical solutions. The Company has a massive opportunity to fundamentally change the way we not only view mental health, but the way we treat mental health indications. Our team will be undertaking an extensive capital markets program over the coming months to highlight the great work that CEO Najla Guthrie and her team have accomplished so far in 2022and provide insight into our plans for the remainder of the year and beyond,” saidNatalie Dolphin, VP of Marketing and Investment Relations.
About Wellbeing Digital Science
Wellbeing Digital Sciences Inc. is an evidence-based mental healthcare company focused on the development and implementation of innovative clinical treatment solutions, including psychedelic medicine and digital therapeutics, as supported by clinical research. Its mission is supported by a network of North American clinics that provide forward-thinking therapies and other types of treatment to patients as well as through a contract research organization that offers clinical trials services to clients pursuing drug development. For additional information, please visit wellbeingdigital.co.
On behalf of:
Najla Guthrie
Chief Executive Officer
WELLBEING DIGITAL SCIENCES
For further information, please contact:
Natalie Dolphin
VP of Marketing & Investment Relations
Email: ir@wellbeingdigital.co
Twitter: @Wellbeing_IR
Notice Regarding Forward-Looking Information:
This news release contains forward-looking statements including but not limited to statements regarding the Company’s business, assets or investments, as well other statements that are not historical facts. Readers are cautioned not to place undue reliance on forward-looking statements, as there can be no assurance that the plans, intentions or expectations upon which they are based will occur. By their nature, forward-looking statements involve numerous assumptions, known and unknown risks and uncertainties, both general and specific, that contribute to the possibility that the predictions, forecasts, projections and other forward-looking statements will not occur, which may cause actual performance and results in future periods to differ materially from any estimates or projections of future performance or results expressed or implied by such forward-looking statements. These assumptions, risks and uncertainties include, among other things, the state of the economy in general and capital markets in particular, investor interest in the business and prospects of theCompany.
The forward-looking statements contained in this news release are made as of the date of this news release. Except as required by law, theCompany disclaims any intention and assumes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable securities law.Additionally, the Company undertakes no obligation to comment on the expectations of, or statements made, by third parties in respect of the matters discussed above.